LSK BioPartner, Inc. ("LSKB") is an international health care product development company. LSKB is dedicated to creating and adding value to new and innovative health care products. LSKB's business strategy is focused on development of a next generation cancer drug and providing product development services to international pharmaceutical companies. Developing products in the life-science industry requires extensive resources and in depth experience. LSKB management has extensive international experience in pharmaceutical product development. This experience includes business development, US, EU and Korean regulatory practices, and preclinical and clinical development. LSKB was founded in 2005 and is a privately held corporation based in Salt Lake City, Utah, with offices in the US and Korea. LSKB provides international product development expertise in US, Korean and European regulatory practices as well as preclinical and clinical development planning. LSKB's professionals assist international clients in partnering at all stages of licensing activities, from initial contact to strategy development, post-deal management to aggressively planning and executing innovative business strategies and transaction management.